Dendritic cells (DC) represent an important linkage between the innate and adoptive immune system and express pro-inflammatory transcriptomic products early after trauma. Using a genomic approach, platelet factor 4 (PF4) was recently found significantly up-regulated in DCs following multiple trauma. However, knowledge about subsequent PF4 alteration and its potential clinical relevance in the context of multiple trauma is still limited.
Introduction

Determination of HLA-DR on dendritic cells
The HLA-DR surface expression on MDC and PDC was determined in whole blood as follows. Each 10 µl of CD11-PerCPCy5, CD303-APC, HLA-DR-PE and a FITClabelled lineage negative cocktail were added to each 200 µl of consequently cooled (4°C) EDTA-blood. A parallel preparation containing fluorochrome conjugated isotype identical antibodies served as control. After 15 min of incubation red cells were lysed and the preparations were washed twice and subjected immediately to flow cytometry. The general gating strategy applied is described in figure 1 .
Determination of DC-adhesion on endothelial cells
The adhesion assay was performed as described in (16) . Briefly, PBMC derived from trauma patients or controls were incubated in a density of 2 ×10 5 per cm 2 on a confluent monolayer consisting of human umbilical endothelial cells (HUVEC) for 1 h.
The HUVEC were gently gifted by Dr. Roman Blaheta, Department of Urology, Johann Wolfgang Goethe-University, Frankfurt.
The non-adherent cells were removed by aspiration of the culture medium. To remove weak adherent cells the monolayer with the remaining adhering PBMCs was gently rinsed three times with warm PBS (containing Mg 2+ and Ca 2+ ; PBS +/+ ) and then subjected to phase contrast microscopy.
Adhering cells were counted in ten randomized field of views (FOV) at a power of 100
x and the mean cell number/FOV was calculated. Based on the mean PBMC number per FOV the absolute number of PBMC per well was extrapolated. Next, HUVECs and adherent cells were detached by thoroughly and repeated aspiration and the percentage MDC and PDC of PBMC within this preparation was determined by flow cytometry as indicated above. PBMC and HUVECs were distinguished by their for-
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www.molmed.org UNCORRECTED PROOF ward and sideward scatter properties. In addition the absolute number of MDC and PDC, respectively, was calculated by multiplying the corresponding percentage with the microscopically determined absolute number of PBMC.
Isolation of peripheral blood DC for gene expression analysis and purity check
The analysis of PF-4 gene expression was performed using highly purified DC obtained from 10 ml anti-coagulated peripheral blood. Blood samples were drawn into ethylene diaminetetraacetic acid (EDTA) tubes on the day of admission (day 0) as well as on day 1 and day 4. The blood samples were placed on ice and were immediately subjected to the DC isolation procedure which was carried out at continuously low temperatures (4°C) in order to prevent changes of PF4 gene expression.
DCs were isolated by using a magnetic separation technique (Blood dendritic cell isolation Kit II, Miltenyi Biotech, Bergisch-Gladbach, Germany) according to the manufacturer's instructions. In brief, the isolation was performed in a two-step procedure. First, B cells and monocytes were magnetically labelled and depleted using a cocktail of CD19 and CD14 MicroBeads. B cells and monocytes were depleted in advance because a subpopulation of B cells expresses CD1c (BDCA-1), and monocytes express CD141 (BDCA-3) at low levels. Subsequently, the pre-enriched dendritic cells in the non-magnetic flow-through fraction were magnetically labeled and enriched using a cocktail of antibodies against the dendritic cell markers CD304 (BDCA-4/Neuropilin-1, PDC), CD141 (BDCA-3, PDC), and CD1c (BDCA-1, MDC).
The highly pure enriched cell fraction comprises of plasmacytoid dendritic cells, CD1c
(BDCA-1)+ type-1 myeloid dendritic cells (MDC1s), and CD1c (BDCA-1)-CD141 (BDCA-3) bright type-2 myeloid dendritic cells (MDC2s). The whole procedure re-Molecular Medicine www.molmed.org
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Discussion
The present study shows for the first time that the PF4 expression in the main dendritic cell subtypes -the PDC and the MDC -is significantly increased starting on day 1 and is maintained until day 4 after multiple trauma. A similar time scheme has been observed with other markers (e.g. CRP, PCT, LPS stimulated IL-1β synthesis) of inflammation during the posttraumatic inflammatory response (17, 18). Moreover, a trauma-associated differential activation of dendritic cell subtypes with regard to the surface expression of HLA-DR can be found with enhanced expression on MDCs in contrast to PDCs. These results confirm and significantly extend our recent study where we demonstrated that PF4 is upregulated in DC following multiple trauma.
The DC subtypes show tremendous differences concerning their cell surface receptors as well as the production of chemokines (13). This leads to different migratory properties and individual capacity to recruit different cell types at the site of inflammation (14). In a recent study we have shown that the clinical trauma impact leads to a decreasing number of MDC while PDC are not affected which seems to be related to increased apoptosis of this cell type (17, 19) . Therefore the results of this study are presented with the analysis of the two subtypes MDC and PDC.
Preliminary microcroarray analysis over 5 days following trauma revealed a significant increase of PF4 gene expression until day 4 and a slight decrease afterwards (day 5). We therefore chose to analyze day 1 and day 4 for the following measurements. Therefore, however, we still do not know how PF4 is regulated during the subsequent period e.g. when secondary complications like sepsis or organ failure occur.
Originally PF4 was thought to be solely produced in platelets and this production was related to platelet associated diseases like heparin-induced thrombocytopenia and Molecular Medicine www.molmed.org
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autoimmune thrombocytopenic disorders (20). However, a number of recent studies revealed the complex role of PF4 within the microcirculation and immune system (7,
21-23). Different immune competent cells like monocytes, macrophages, neutrophils
and T-cells have been shown to produce and interact with PF4 (2, 5, 24). It has been speculated that the role of PF4 after trauma might be the increase of cell adhesion as this has been reported for neutrophils in other studies (7, 25, 26). However, cell specific data regarding PF4 in a human population is rare and in trauma it has not been reported to our knowledge.
Severe trauma leads to an early activation of DC transcription with a significant increase over the first days as qRT-PCR showed in this study. Intracellular PF4 was significantly increased in both DC subtypes (MDC and PDC) on day 1 when compared to controls. However, the stimulatory response of DC concerning the production of PF4 observed on day 1 does not further increase until day 4 after trauma in both DC subtypes. It seems that the activation upon the trauma impact does not allow further stimulation. Although this has not been yet observed in DC there is a consent on experimental and clinical data that the overactivation of the immune system after severe trauma is often followed by a period of immunosupression (27, 28). Our data might support this observation in DC however, more specific investigations are necessary to support this hypothesis. Intracellular PF4 synthesis did not show any difference between the subtypes of MDC and PDC. This is coherent with the results of an earlier publication showing that some chemokines are predominantly produced by MDC (CCL17, CCL22) and PDC (CCR1, CCR5) others like CCL4 (PF4) and CXCL8 are produced in both subtypes (13). However, in vitro stimulation of MDC and PDC with PMA showed a further significant increase of intracellular PF4 only for MDC and this increase was observed on day 1 and day 4 after trauma (Fig.4) . As We found a significant correlation between ISS and and HLA-DR only for MDC but not for PDC, a difference that highlights the functional variabilities of DC subtypes Day 1 1.9 × 10 4 ± 0.7 × 10 4 5.3 × 10 4 ± 2.2 × 10 4 42.1 ± 3.1
Day 4 0.8 × 10 4 ± 0.5 × 10 4 4.6 × 10 4 ± 1.0 × 10 4 42.9 ± 3.7 
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